Zimbabwe legalized the cultivation of cannabis for medicinal and scientific purposes, making it only the second country in Africa to lay the groundwork for a medical marijuana industry.
Details of the country’s cannabis regulations were announced in the government gazette on Friday, according to Zimbabwe’s state-owned newspaper, The Herald. (The gazette prints official notices and laws from the government.)
Five-year renewable licenses would allow growers to possess, transport and sell cannabis oil and fresh and dried cannabis, according to Reuters, which reported to have viewed Zimbabwe’s regulations.
“In the case of a company, proof of citizenship or proof of being ordinarily resident in Zimbabwe of the majority of directors or proof of an exemption by the Minister and proof of incorporation in Zimbabwe of the company…” according to the regulations.
Production must be licensed by the Ministry of Health and Child Welfare.
No details are available on whether imports or exports would be permitted or how local MMJ consumption would be regulated.
Miles Light at the Marijuana Policy Group, a Denver consulting firm that advises governments on legalization, said it’s a significant first step.
“Zimbabwe’s business sector understands that it’s easier to legalize production than consumption,” Light said. “Production is generally profitable and easy to tax, while legal consumption laws are typically controversial and politically risky.”
Marijuana Policy Group was not involved in Zimbabwe’s regulatory changes.
Light noted that several considerations still need to be addressed, such as how exports will be organized and what sort of testing and import-export controls exist in Zimbabwe to ensure that cannabis is safe, free of pesticides and chemicals, and contains cannabinoid levels stated on the packages.
Zimbabwean officials did not immediately return queries from Marijuana Business Daily.
Lesotho, a landlocked nation in southern Africa, was the first African nation to legalize cultivation, and it is already on the cusp of opening major medical cannabis opportunities both domestically and internationally.
Matt Lamers can be reached at email@example.com